The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Guard Medical sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Guard Medical is a medical device company that develops devices for surgical patients. Its products help to reduce surgical site infections while making negative pressure wound therapy (NPWT) more accessible. The company’s major product, NPseal is a device that improves the lives of surgical patients through NPWT and promotes wound healing while lowering infection. It is an ultra-portable negative pressure wound therapy dressing that does not require batteries, straps and tubes. Guard Medical is headquartered in Miami, Florida, the US.
The key metrics of Guard Medical related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Guard Medical is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Guard Medical.
For a detailed understanding of the performance of Guard Medical, buy the report here.